These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26520013)

  • 1. Impact of Carvedilol versus β1-selective β blockers (bisoprolol, metoprolol, and nebivolol) in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Seo GW; Kim DK; Kim KH; Seol SH; Jin HY; Yang TH; Ahn Y; Jeong MH; Song PS; Kim DI;
    Am J Cardiol; 2015 Nov; 116(10):1502-8. PubMed ID: 26520013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol).
    DiNicolantonio JJ; Lavie CJ; Fares H; Menezes AR; O'Keefe JH
    Am J Cardiol; 2013 Mar; 111(5):765-9. PubMed ID: 23290925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol versus metoprolol in patients undergoing direct percutaneous coronary interventions for myocardial infarction: effects on QT dynamicity.
    Bonnemeier H; Ortak J; Tölg R; Witt M; Schmidt J; Wiegand UK; Bode F; Schunkert H; Richardt G
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S217-21. PubMed ID: 15683500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors Following Contemporary Treatments in Patients with Acute Myocardial Infarction: Results from the Korean Working Group in Myocardial Infarction (KorMI) Registry.
    Song PS; Seol SH; Seo GW; Kim DK; Kim KH; Yang JH; Hahn JY; Gwon HC; Ahn Y; Jeong MH; Song YB; Kim DI;
    Am J Cardiovasc Drugs; 2015 Dec; 15(6):439-49. PubMed ID: 26153396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.
    Fröhlich H; Torres L; Täger T; Schellberg D; Corletto A; Kazmi S; Goode K; Grundtvig M; Hole T; Katus HA; Cleland JGF; Atar D; Clark AL; Agewall S; Frankenstein L
    Clin Res Cardiol; 2017 Sep; 106(9):711-721. PubMed ID: 28434020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Yang JH; Hahn JY; Song YB; Choi SH; Choi JH; Lee SH; Kim JH; Ahn YK; Jeong MH; Choi DJ; Park JS; Kim YJ; Park HS; Han KR; Rha SW; Gwon HC
    JACC Cardiovasc Interv; 2014 Jun; 7(6):592-601. PubMed ID: 24947717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction.
    Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Lee SE; Kim JJ; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Cho MC; Park HY; Oh BH
    Korean J Intern Med; 2019 Sep; 34(5):1030-1039. PubMed ID: 30317846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-Analysis Comparing Metoprolol and Carvedilol on Mortality Benefits in Patients With Acute Myocardial Infarction.
    Li J; Chen Z; Gao X; Zhang H; Xiong W; Ju J; Xu H
    Am J Cardiol; 2017 Nov; 120(9):1479-1486. PubMed ID: 28882337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol versus metoprolol in the acute phase of myocardial infarction:
    Bonnemeier H; Ortak J; Tölg R; Witt M; Schmidt J; Wiegand UK; Bode F; Schunkert H; Richardt G
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S222-6. PubMed ID: 15683501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population.
    Bocchi EA; Böhm M; Borer JS; Ford I; Komajda M; Swedberg K; Tavazzi L;
    Cardiology; 2015; 131(4):218-24. PubMed ID: 25968495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure.
    Marazzi G; Iellamo F; Volterrani M; Caminiti G; Madonna M; Arisi G; Massaro R; Righi D; Rosano GM
    Am J Cardiol; 2011 Jan; 107(2):215-9. PubMed ID: 21129714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.
    Perreault S; de Denus S; White M; White-Guay B; Bouvier M; Dorais M; Dubé MP; Rouleau JL; Tardif JC; Jenna S; Haibe-Kains B; Leduc R; Deblois D
    Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):81-90. PubMed ID: 27859924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nebivolol versus Carvedilol or Metoprolol in Patients Presenting with Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction.
    Ozaydin M; Yucel H; Kocyigit S; Adali MK; Aksoy F; Kahraman F; Uysal BA; Erdogan D; Varol E; Dogan A
    Med Princ Pract; 2016; 25(4):316-22. PubMed ID: 27164841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
    Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Blocker therapy and cardiovascular outcomes in patients who have undergone percutaneous coronary intervention after ST-elevation myocardial infarction.
    Bao B; Ozasa N; Morimoto T; Furukawa Y; Nakagawa Y; Kadota K; Iwabuchi M; Shizuta S; Shiomi H; Tada T; Tazaki J; Kato Y; Hayano M; Natsuaki M; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T
    Cardiovasc Interv Ther; 2013 Apr; 28(2):139-47. PubMed ID: 23054967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure: Carvedilol or Metoprolol Evaluation Study.
    Fröhlich H; Zhao J; Täger T; Cebola R; Schellberg D; Katus HA; Grundtvig M; Hole T; Atar D; Agewall S; Frankenstein L
    Circ Heart Fail; 2015 Sep; 8(5):887-96. PubMed ID: 26175538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of beta blockade therapy on long-term mortality after ST-segment elevation acute myocardial infarction in the percutaneous coronary intervention era.
    Nakatani D; Sakata Y; Suna S; Usami M; Matsumoto S; Shimizu M; Hara M; Uematsu M; Fukunami M; Hamasaki T; Sato H; Hori M; Komuro I;
    Am J Cardiol; 2013 Feb; 111(4):457-64. PubMed ID: 23228922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort study.
    Sessa M; Mascolo A; Mortensen RN; Andersen MP; Rosano GMC; Capuano A; Rossi F; Gislason G; Enghusen-Poulsen H; Torp-Pedersen C
    Eur J Heart Fail; 2018 Mar; 20(3):548-556. PubMed ID: 29159953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized active-controlled study comparing effects of treatment with carvedilol versus metoprolol in patients with left ventricular dysfunction after acute myocardial infarction.
    Mrdovic IB; Savic LZ; Perunicic JP; Asanin MR; Lasica RM; Jelena MM; Matic MD; Vasiljevic ZM; Ostojic MC
    Am Heart J; 2007 Jul; 154(1):116-22. PubMed ID: 17584563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.